Knowledge Center

Implantable Pump Concerns

Category: Quality Assurance

I have become aware of a potential problem regarding programming of implantable infusion pumps that I wish to share. As you are aware, Hartley provides medications for a large number of implantable practices throughout the United States. Recently, I became aware of a problem that occurred with one of our clients. He had inherited a […]

Read More

FDA News

Category: Regulatory

Increased Regulations And Inspections Of Sterile Compounding Pharmacies In light of recent events from the New England Compounding Center Pharmacy tragedy, both state and federal agencies have increased regulations and inspections of sterile compounding pharmacies. Specifically, the FDA has initiated a significant program of inspecting sterile compounding pharmacies nationwide. For reference, pharmacies are regulated by […]

Read More

Survey For Study On The Safety Of Intraspinal Treatments (For Non-Physician Clinicians)

Category: Clinical

I would like to introduce Gail McGlothlen RN, certified in pain management, as she is conducting a very insightful study on the safety of intraspinal treatments. The focus of the study is to query non-physician clinicians who are involved in treating patients with implantable drug delivery devices (IDD). Dr. Lawrence Poree is a member of […]

Read More

New Client Site Visitation And Survey = Peace Of Mind

Category: About Hartley Medical

Hartley Medical has written many times in the past on the importance of physicians visiting your compounding pharmacy, but today I would like to share another relevant event that occurred over the past two months at Hartley Medical. In early June, a relatively new client from the San Diego area contacted us with some quality […]

Read More

Strong Relationships Valued

Category: About Hartley Medical

As you can see on the left, I am not one accustomed to taking “selfie” photographs of myself. But every now and then, a digital image captures a special moment. In April, I flew to Hawaii to visit clients who practice there. I spent two days in Honolulu seeing clients over lunch and dinner reconnecting […]

Read More

FDA Warning Of Medication Stored In Becton-Dickinson (BD) Syringes

Category: Clinical

In September, the FDA and BD issued health alert warning concerning the loss of potency of certain drugs that are stored in BD syringes. These notifications have cited reports of decreased potency of certain drugs when stored in certain lots of 1ml, 3ml, 5ml, 10ml, 20ml and 30ml BD syringes. BD stated in their letter […]

Read More

Workers’ Compensation IDD Treatment: Call To Action

Category: Regulatory

Some of you may be aware of a possible trend occurring with a state agency’s policies affecting the treatment of chronic pain. In December of 2014, the Division of Workers’ Compensation proposed new guidelines that would affect injured workers’ access to implantable drug delivery (IDD) and spinal cord stimulation (SCS) for the treatment of chronic […]

Read More

International Neuromodulation Society (INS) Meeting – Montreal

Category: Conference Recaps

In June of this year, I attended a day of lectures at the International Neuromodulation Society Annual Meeting. One lecture made a particularly lasting impression. Dr. Joshua Prager gave an excellent presentation on Best Practices for Intrathecal Therapy and the FDA. The FDA portion was a late addition to this presentation, and I shall address […]

Read More

Notations From Across The Pond: Two

Category: About Hartley Medical

(Top photo: William Stuart (second from right) at Hannover Re Group at its headquarters in Hannover, Germany. Bottom Photo: William Stuart (fourth from left) at JLT Towers Re in London.) I have written about my travels in the past, and this is another recitation of my observations and experience that I have gained from my recent business trip to […]

Read More

Pain Lawsuit

Category: Regulatory

The District Attorney of Orange County and the Office of Santa Clara County Counsel have filed suit against pharmaceutical manufacturers that produce pain medications. The complaint specifies violations of California false advertising law, unfair competition, and public nuisance for which they are seeking restitution and civil penalties. The volume of this complaint is quite alarming […]

Read More